|
1
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Alvarez SW, Sviderskiy VO, Terzi EM,
Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K
and Possemato R: NFS1 undergoes positive selection in lung tumours
and protects cells from ferroptosis. Nature. 551:639–643.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lee JY, Nam M, Son HY, Hyun K, Jang SY,
Kim JW, Kim MW, Jung Y, Jang E, Yoon SJ, et al: Polyunsaturated
fatty acid biosynthesis pathway determines ferroptosis sensitivity
in gastric cancer. Proc Natl Acad Sci USA. 117:32433–32442.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Fang X, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Natl Acad Sci USA.
116:2672–2680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Park MW, Cha HW, Kim J, Kim JH, Yang H,
Yoon S, Boonpraman N, Yi SS, Yoo ID and Moon JS: NOX4 promotes
ferroptosis of astrocytes by oxidative stress-induced lipid
peroxidation via the impairment of mitochondrial metabolism in
Alzheimer's diseases. Redox Biol. 41(101947)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Do Van B, Gouel F, Jonneaux A, Timmerman
K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, et
al: Ferroptosis, a newly characterized form of cell death in
Parkinson's disease that is regulated by PKC. Neurobiol Dis.
94:169–178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hayter SM and Cook MC: Updated assessment
of the prevalence, spectrum and case definition of autoimmune
disease. Autoimmun Rev. 11:754–765. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cho JH and Gregersen PK: Genomics and the
multifactorial nature of human autoimmune disease. N Engl J Med.
365:1612–1623. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lai B, Wu CH, Wu CY, Luo SF and Lai JH:
Ferroptosis and autoimmune diseases. Front Immunol.
13(916664)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fan J, Jiang T and He D: Emerging insights
into the role of ferroptosis in the pathogenesis of autoimmune
diseases. Front Immunol. 14(1120519)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ohl K, Rauen T and Tenbrock K:
Dysregulated neutrophilic cell death in SLE: A spotlight on
ferroptosis. Signal Transduct Target Ther. 6(392)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu H, Chen Y, Jing L, Zhai C and Shen L:
The link between ferroptosis and cardiovascular diseases: A novel
target for treatment. Front Cardiovasc Med.
8(710963)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP cyclohydrolase
1/tetrahydrobiopterin counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iwasaki A and Medzhitov R: Control of
adaptive immunity by the innate immune system. Nat Immunol.
16:343–353. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Yang Y, Wang Y, Guo L, Gao W, Tang TL and
Yan M: Interaction between macrophages and ferroptosis. Cell Death
Dis. 13(355)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Stockwell BR and Jiang X: A physiological
function for ferroptosis in tumor suppression by the immune system.
Cell Metab. 30:14–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Akirav EM, Ruddle NH and Herold KC: The
role of AIRE in human autoimmune disease. Nat Rev Endocrinol.
7:25–33. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Matsushita M, Freigang S, Schneider C,
Conrad M, Bornkamm GW and Kopf M: T cell lipid peroxidation induces
ferroptosis and prevents immunity to infection. J Exp Med.
212:555–568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang W, Green M, Choi JE, Gijón M, Kennedy
PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al:
CD8+ T cells regulate tumour ferroptosis during cancer
immunotherapy. Nature. 569:270–274. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yao Y, Chen Z, Zhang H, Chen C, Zeng M,
Yunis J, Wei Y, Wan Y, Wang N, Zhou M, et al: Selenium-GPX4 axis
protects follicular helper T cells from ferroptosis. Nat Immunol.
22:1127–1139. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shaw J, Chakraborty A, Nag A, Chattopadyay
A, Dasgupta AK and Bhattacharyya M: Intracellular iron overload
leading to DNA damage of lymphocytes and immune dysfunction in
thalassemia major patients. Eur J Haematol. 99:399–408.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Anupam K, Kaushal J, Prabhakar N and
Bhatnagar A: Effect of redox status of peripheral blood on immune
signature of circulating regulatory and cytotoxic T cells in
streptozotocin induced rodent model of type I diabetes.
Immunobiology. 223:586–597. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Muri J, Thut H, Bornkamm GW and Kopf M: B1
and marginal zone B cells but not follicular B2 cells require Gpx4
to prevent lipid peroxidation and ferroptosis. Cell Rep.
29:2731–2744.e4. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang D, Xie N, Gao W, Kang R and Tang D:
The ferroptosis inducer erastin promotes proliferation and
differentiation in human peripheral blood mononuclear cells.
Biochem Biophys Res Commun. 503:1689–1695. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yu B, Choi B, Li W and Kim DH: Magnetic
field boosted ferroptosis-like cell death and responsive MRI using
hybrid vesicles for cancer immunotherapy. Nat Commun.
11(3637)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Efimova I, Catanzaro E, Van der Meeren L,
Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, Fimognari C,
Bachert C, Coppieters F, et al: Vaccination with early ferroptotic
cancer cells induces efficient antitumor immunity. J Immunother
Cancer. 8(e001369)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang Z, Qiu X, Yan Y, Liang Q, Cai Y,
Peng B, Xu Z and Xia F: Evaluation of ferroptosis-related gene
AKR1C1 as a novel biomarker associated with the immune
microenvironment and prognosis in breast cancer. Int J Gen Med.
14:6189–6200. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dai E, Han L, Liu J, Xie Y, Kroemer G,
Klionsky DJ, Zeh HJ, Kang R, Wang J and Tang D: Autophagy-dependent
ferroptosis drives tumor-associated macrophage polarization via
release and uptake of oncogenic KRAS protein. Autophagy.
16:2069–2083. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li W, Feng G, Gauthier JM, Lokshina I,
Higashikubo R, Evans S, Liu X, Hassan A, Tanaka S, Cicka M, et al:
Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil
recruitment after heart transplantation. J Clin Invest.
129:2293–2304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hall SW and Cooke A: Autoimmunity and
inflammation: Murine models and translational studies. Mamm Genome.
22:377–389. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Roh JS and Sohn DH: Damage-associated
molecular patterns in inflammatory diseases. Immune Netw.
18(e27)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gong T, Liu L, Jiang W and Zhou R:
DAMP-sensing receptors in sterile inflammation and inflammatory
diseases. Nat Rev Immunol. 20:95–112. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Schaper F, Westra J and Bijl M: Recent
developments in the role of high-mobility group box 1 in systemic
lupus erythematosus. Mol Med. 20:72–79. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Boyapati RK, Dorward DA, Tamborska A,
Kalla R, Ventham NT, Doherty MK, Whitfield PD, Gray M, Loane J,
Rossi AG, et al: Mitochondrial DNA is a pro-inflammatory
damage-associated molecular pattern released during active IBD.
Inflamm Bowel Dis. 24:2113–2122. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Freire Boullosa L, Van Loenhout J,
Flieswasser T, De Waele J, Hermans C, Lambrechts H, Cuypers B,
Laukens K, Bartholomeus E, Siozopoulou V, et al: Auranofin reveals
therapeutic anticancer potential by triggering distinct molecular
cell death mechanisms and innate immunity in mutant p53 non-small
cell lung cancer. Redox Biol. 42(101949)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu M, Fan Y, Li D, Han B, Meng Y, Chen F,
Liu T, Song Z, Han Y, Huang L, et al: Ferroptosis inducer erastin
sensitizes NSCLC cells to celastrol through activation of the
ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 15:2084–2105.
2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen C, Wang D, Yu Y, Zhao T, Min N, Wu Y,
Kang L, Zhao Y, Du L, Zhang M, et al: Legumain promotes tubular
ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in
AKI. Cell Death Dis. 12(65)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhao YY, Lian JX, Lan Z, Zou KL, Wang WM
and Yu GT: Ferroptosis promotes anti-tumor immune response by
inducing immunogenic exposure in HNSCC. Oral Dis. 29:933–941.
2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Van Loenhout J, Freire Boullosa L,
Quatannens D, De Waele J, Merlin C, Lambrechts H, Lau HW, Hermans
C, Lin A, Lardon F, et al: Auranofin and cold atmospheric plasma
synergize to trigger distinct cell death mechanisms and immunogenic
responses in glioblastoma. Cells. 10(2936)2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Martin-Sanchez D, Ruiz-Andres O, Poveda J,
Carrasco S, Cannata-Ortiz P, Sanchez-Niño MD, Ruiz Ortega M, Egido
J, Linkermann A, Ortiz A and Sanz AB: Ferroptosis, but not
necroptosis, is important in nephrotoxic folic acid-induced AKI. J
Am Soc Nephrol. 28:218–229. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Li X, Duan L, Yuan S, Zhuang X, Qiao T and
He J: Ferroptosis inhibitor alleviates radiation-induced lung
fibrosis (RILF) via down-regulation of TGF-β1. J Inflamm (Lond).
16(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhernakova A, Withoff S and Wijmenga C:
Clinical implications of shared genetics and pathogenesis in
autoimmune diseases. Nat Rev Endocrinol. 9:646–659. 2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Mack CL, Adams D, Assis DN, Kerkar N,
Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH and Czaja AJ:
Diagnosis and management of autoimmune hepatitis in adults and
children: 2019 Practice guidance and guidelines from the American
association for the study of liver diseases. Hepatology.
72:671–722. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Deng G, Li Y, Ma S, Gao Z, Zeng T, Chen L,
Ye H, Yang M, Shi H, Yao X, et al: Caveolin-1 dictates ferroptosis
in the execution of acute immune-mediated hepatic damage by
attenuating nitrogen stress. Free Radic Biol Med. 148:151–161.
2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zhu L, Chen D, Zhu Y, Pan T, Xia D, Cai T,
Lin H, Lin J, Jin X, Wu F, et al: GPX4-regulated ferroptosis
mediates S100-induced experimental autoimmune hepatitis associated
with the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev.
2021(6551069)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Singh JA, Saag KG, Bridges SL Jr, Akl EA,
Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M,
Shmerling RH, et al: 2015 American college of Rheumatology
guideline for the treatment of rheumatoid arthritis. Arthritis
Rheumatol. 68:1–26. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fraenkel L, Bathon JM, England BR, St
Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK,
Kerr G, et al: 2021 American college of Rheumatology guideline for
the treatment of rheumatoid arthritis. Arthritis Rheumatol.
73:1108–1123. 2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wu J, Feng Z, Chen L, Li Y, Bian H, Geng
J, Zheng ZH, Fu X, Pei Z, Qin Y, et al: TNF antagonist sensitizes
synovial fibroblasts to ferroptotic cell death in collagen-induced
arthritis mouse models. Nat Commun. 13(676)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Floros KV, Cai J, Jacob S, Kurupi R,
Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B, et al:
MYCN-amplified neuroblastoma is addicted to iron and vulnerable to
inhibition of the system Xc-/glutathione axis. Cancer Res.
81:1896–1908. 2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ling H, Li M, Yang C, Sun S, Zhang W, Zhao
L, Xu N, Zhang J, Shen Y, Zhang X, et al: Glycine increased
ferroptosis via SAM-mediated GPX4 promoter methylation in
rheumatoid arthritis. Rheumatology (Oxford). 61:4521–4534.
2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Luo H and Zhang R: Icariin enhances cell
survival in lipopolysaccharide-induced synoviocytes by suppressing
ferroptosis via the Xc-/GPX4 axis. Exp Ther Med.
21(72)2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Gordon C, Amissah-Arthur MB, Gayed M,
Brown S, Bruce IN, D'Cruz D, Empson B, Griffiths B, Jayne D,
Khamashta M, et al: The British Society for Rheumatology guideline
for the management of systemic lupus erythematosus in adults.
Rheumatology (Oxford). 57:e1–e45. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Tsokos GC, Lo MS, Costa Reis P and
Sullivan KE: New insights into the immunopathogenesis of systemic
lupus erythematosus. Nat Rev Rheumatol. 12:716–730. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Indrakanti DL, Alvarado A, Zhang X,
Birmingham DJ, Hinton A and Rovin BH: The
interleukin-6-hepcidin-hemoglobin circuit in systemic lupus
erythematosus flares. Lupus. 26:200–203. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chen W, Li W, Zhang Z, Tang X, Wu S, Yao
G, Li K, Wang D, Xu Y, Feng R, et al: Lipocalin-2 exacerbates lupus
nephritis by promoting Th1 cell differentiation. J Am Soc Nephrol.
31:2263–2277. 2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Scindia Y, Wlazlo E, Ghias E, Cechova S,
Loi V, Leeds J, Ledesma J, Helen C and Swaminathan S: Modulation of
iron homeostasis with hepcidin ameliorates spontaneous murine lupus
nephritis. Kidney Int. 98:100–115. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X,
Xu Y, Krishfield S, Lipsky PE, Tsokos GC and Zhang X: Glutathione
peroxidase 4-regulated neutrophil ferroptosis induces systemic
autoimmunity. Nat Immunol. 22:1107–1117. 2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ananthakrishnan AN: Epidemiology and risk
factors for IBD. Nat Rev Gastroenterol Hepatol. 12:205–217.
2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Guan Q: A comprehensive review and update
on the pathogenesis of inflammatory bowel disease. J Immunol Res.
2019(7247238)2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Mayr L, Grabherr F, Schwärzler J,
Reitmeier I, Sommer F, Gehmacher T, Niederreiter L, He GW, Ruder B,
Kunz KTR, et al: Dietary lipids fuel GPX4-restricted enteritis
resembling Crohn's disease. Nat Commun. 11(1775)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Xu J, Liu S, Cui Z, Wang X, Ning T, Wang
T, Zhang N, Xie S, Min L, Zhang S, et al: Ferrostatin-1 alleviated
TNBS induced colitis via the inhibition of ferroptosis. Biochem
Biophys Res Commun. 573:48–54. 2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Xu M, Tao J, Yang Y, Tan S, Liu H, Jiang
J, Zheng F and Wu B: Ferroptosis involves in intestinal epithelial
cell death in ulcerative colitis. Cell Death Dis.
11(86)2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Chen Y, Wang J, Li J, Zhu J, Wang R, Xi Q,
Wu H, Shi T and Chen W: Astragalus polysaccharide prevents
ferroptosis in a murine model of experimental colitis and human
Caco-2 cells via inhibiting NRF2/HO-1 pathway. Eur J Pharmacol.
911(174518)2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Chen Y, Zhang P, Chen W and Chen G:
Ferroptosis mediated DSS-induced ulcerative colitis associated with
Nrf2/HO-1 signaling pathway. Immunol Lett. 225:9–15.
2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Montalban X, Gold R, Thompson AJ,
Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss
T, Fazekas F, et al: ECTRIMS/EAN guideline on the pharmacological
treatment of people with multiple sclerosis. Eur J Neurol.
25:215–237. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Hemmer B, Archelos JJ and Hartung HP: New
concepts in the immunopathogenesis of multiple sclerosis. Nat Rev
Neurosci. 3:291–301. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
70
|
Hu CL, Nydes M, Shanley KL, Morales
Pantoja IE, Howard TA and Bizzozero OA: Reduced expression of the
ferroptosis inhibitor glutathione peroxidase-4 in multiple
sclerosis and experimental autoimmune encephalomyelitis. J
Neurochem. 148:426–439. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Jhelum P, Santos-Nogueira E, Teo W,
Haumont A, Lenoël I, Stys PK and David S: Ferroptosis mediates
cuprizone-induced loss of oligodendrocytes and demyelination. J
Neurosci. 40:9327–9341. 2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Stewart DA: NICE guideline for Parkinson's
disease. Age Ageing. 36:240–242. 2007.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Sulzer D, Alcalay RN, Garretti F, Cote L,
Kanter E, Agin-Liebes J, Liong C, McMurtrey C, Hildebrand WH, Mao
X, et al: T cells from patients with Parkinson's disease recognize
α-synuclein peptides. Nature. 546:656–661. 2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Thapa K, Khan H, Kanojia N, Singh TG, Kaur
A and Kaur G: Therapeutic insights on ferroptosis in Parkinson's
disease. Eur J Pharmacol. 930(175133)2022.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Zhang P, Chen L, Zhao Q, Du X, Bi M, Li Y,
Jiao Q and Jiang H: Ferroptosis was more initial in cell death
caused by iron overload and its underlying mechanism in Parkinson's
disease. Free Radic Biol Med. 152:227–234. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Dexter DT, Wells FR, Lees AJ, Agid F, Agid
Y, Jenner P and Marsden CD: Increased nigral iron content and
alterations in other metal ions occurring in brain in Parkinson's
disease. J Neurochem. 52:1830–1836. 1989.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Dexter DT, Carter CJ, Wells FR, Javoy-Agid
F, Agid Y, Lees A, Jenner P and Marsden CD: Basal lipid
peroxidation in substantia nigra is increased in Parkinson's
disease. J Neurochem. 52:381–389. 1989.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Sofic E, Lange KW, Jellinger K and
Riederer P: Reduced and oxidized glutathione in the substantia
nigra of patients with Parkinson's disease. Neurosci Lett.
142:128–130. 1992.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Zuo Y, Xie J, Li X, Li Y, Thirupathi A,
Zhang J, Yu P, Gao G, Chang Y and Shi Z: Ferritinophagy-mediated
ferroptosis involved in paraquat-induced neurotoxicity of
dopaminergic neurons: Implication for neurotoxicity in PD. Oxid Med
Cell Longev. 2021(9961628)2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Parisi R, Iskandar IYK, Kontopantelis E,
Augustin M, Griffiths CEM and Ashcroft DM: Global Psoriasis Atlas.
National, regional, and worldwide epidemiology of psoriasis:
Systematic analysis and modelling study. BMJ.
369(m1590)2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Arbiser JL, Bonner MY, Ward N, Elsey J and
Rao S: Selenium unmasks protective iron armor: A possible defense
against cutaneous inflammation and cancer. Biochim Biophys Acta Gen
Subj. 1862:2518–2527. 2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Shou Y, Yang L, Yang Y and Xu J:
Inhibition of keratinocyte ferroptosis suppresses psoriatic
inflammation. Cell Death Dis. 12(1009)2021.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Atkinson MA and Maclaren NK: The
pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med.
331:1428–1436. 1994.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Zang H, Wu W, Qi L, Tan W, Nagarkatti P,
Nagarkatti M, Wang X and Cui T: Autophagy inhibition enables Nrf2
to exaggerate the progression of diabetic cardiomyopathy in mice.
Diabetes. 69:2720–2734. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ni T, Huang X, Pan S and Lu Z: Inhibition
of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging
miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J
Cell Mol Med. 25:9995–10007. 2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Li S, Zheng L, Zhang J, Liu X and Wu Z:
Inhibition of ferroptosis by up-regulating Nrf2 delayed the
progression of diabetic nephropathy. Free Radic Biol Med.
162:435–449. 2021.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Kim S, Kang SW, Joo J, Han SH, Shin H, Nam
BY, Park J, Yoo TH, Kim G, Lee P and Park JT: Characterization of
ferroptosis in kidney tubular cell death under diabetic conditions.
Cell Death Dis. 12(160)2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Bruni A, Bornstein S, Linkermann A and
Shapiro AMJ: Regulated cell death seen through the lens of islet
transplantation. Cell Transplant. 27:890–901. 2018.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Krümmel B, Plötz T, Jörns A, Lenzen S and
Mehmeti I: The central role of glutathione peroxidase 4 in the
regulation of ferroptosis and its implications for pro-inflammatory
cytokine-mediated beta-cell death. Biochim Biophys Acta Mol Basis
Dis. 1867(166114)2021.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Fudman EJ, Till GO and Fox IH:
Deferoxamine induced decreases of lipid peroxides in rheumatoid
arthritis. J Rheumatol. 14:686–691. 1987.PubMed/NCBI
|
|
91
|
Salvarani C, Baricchi R, Lasagni D,
Boiardi L, Piccinini R, Brunati C, Macchioni P and Portioli I:
Effects of desferrioxamine therapy on chronic disease anemia
associated with rheumatoid arthritis. Rheumatol Int. 16:45–48.
1996.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Lynch SG, Peters K and LeVine SM:
Desferrioxamine in chronic progressive multiple sclerosis: A pilot
study. Mult Scler. 2:157–160. 1996.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Lynch SG, Fonseca T and LeVine SM: A
multiple course trial of desferrioxamine in chronic progressive
multiple sclerosis. Cell Mol Biol (Noisy-le-grand). 46:865–869.
2000.PubMed/NCBI
|
|
94
|
Febbraro F, Andersen KJ, Sanchez-Guajardo
V, Tentillier N and Romero-Ramos M: Chronic intranasal deferoxamine
ameliorates motor defects and pathology in the α-synuclein rAAV
Parkinson's model. Exp Neurol. 247:45–58. 2013.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Sweeney ME, Slusser JG, Lynch SG, Benedict
SH, Garcia SL, Rues L and LeVine SM: Deferiprone modulates in vitro
responses by peripheral blood T cells from control and
relapsing-remitting multiple sclerosis subjects. Int
Immunopharmacol. 11:1796–1801. 2011.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Devos D, Moreau C, Devedjian JC, Kluza J,
Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N,
et al: Targeting chelatable iron as a therapeutic modality in
Parkinson's disease. Antioxid Redox Signal. 21:195–210.
2014.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Yang B, Hou S, Huang S, Li H and Li Y:
Ferroptosis inhibitor regulates the disease progression of
systematic lupus erythematosus mice model through Th1/Th2 ratio.
Curr Mol Med: May 25, 2022 (Epub ahead of print).
|
|
98
|
Hinman A, Holst CR, Latham JC, Bruegger
JJ, Ulas G, McCusker KP, Amagata A, Davis D, Hoff KG, Kahn-Kirby
AH, et al: Vitamin E hydroquinone is an endogenous regulator of
ferroptosis via redox control of 15-lipoxygenase. PLoS One.
13(e0201369)2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Edmonds SE, Winyard PG, Guo R, Kidd B,
Merry P, Langrish-Smith A, Hansen C, Ramm S and Blake DR: Putative
analgesic activity of repeated oral doses of vitamin E in the
treatment of rheumatoid arthritis. Results of a prospective placebo
controlled double blind trial. Ann Rheum Dis. 56:649–655.
1997.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Aristotelous P, Stefanakis M, Pantzaris M,
Pattichis CS, Calder PC, Patrikios IS, Sakkas GK and Giannaki CD:
The effects of specific omega-3 and omega-6 polyunsaturated fatty
acids and antioxidant vitamins on gait and functional capacity
parameters in patients with relapsing-remitting multiple sclerosis.
Nutrients. 13(3661)2021.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Taghizadeh M, Tamtaji OR, Dadgostar E,
Daneshvar Kakhaki R, Bahmani F, Abolhassani J, Aarabi MH, Kouchaki
E, Memarzadeh MR and Asemi Z: The effects of omega-3 fatty acids
and vitamin E co-supplementation on clinical and metabolic status
in patients with Parkinson's disease: A randomized, double-blind,
placebo-controlled trial. Neurochem Int. 108:183–189.
2017.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Kharaeva Z, Gostova E, De Luca C, Raskovic
D and Korkina L: Clinical and biochemical effects of coenzyme
Q(10), vitamin E, and selenium supplementation to psoriasis
patients. Nutrition. 25:295–302. 2009.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Odinak MM, Bisaga GN and Zarubina IV: New
approaches to antioxidant therapy in multiple sclerosis. Zh Nevrol
Psikhiatr Im S S Korsakova. (Suppl):S72–S75. 2002.PubMed/NCBI(In Russian).
|
|
104
|
Miroliaee AE, Esmaily H, Vaziri-Bami A,
Baeeri M, Shahverdi AR and Abdollahi M: Amelioration of
experimental colitis by a novel nanoselenium-silymarin mixture.
Toxicol Mech Methods. 21:200–208. 2011.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Peretz A, Siderova V and Nève J: Selenium
supplementation in rheumatoid arthritis investigated in a double
blind, placebo-controlled trial. Scand J Rheumatol. 30:208–212.
2001.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Tarp U, Overvad K, Thorling EB, Graudal H
and Hansen JC: Selenium treatment in rheumatoid arthritis. Scand J
Rheumatol. 14:364–368. 1985.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Zafar KS, Siddiqui A, Sayeed I, Ahmad M,
Salim S and Islam F: Dose-dependent protective effect of selenium
in rat model of Parkinson's disease: Neurobehavioral and
neurochemical evidences. J Neurochem. 84:438–446. 2003.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Batooei M, Tahamoli-Roudsari A, Basiri Z,
Yasrebifar F, Shahdoust M, Eshraghi A, Mehrpooya M and Ataei S:
Evaluating the effect of oral N-acetylcysteine as an adjuvant
treatment on clinical outcomes of patients with rheumatoid
arthritis: A randomized, double blind clinical trial. Rev Recent
Clin Trials. 13:132–138. 2018.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Lai ZW, Hanczko R, Bonilla E, Caza TN,
Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, et al:
N-acetylcysteine reduces disease activity by blocking mammalian
target of rapamycin in T cells from systemic lupus erythematosus
patients: A randomized, double-blind, placebo-controlled trial.
Arthritis Rheum. 64:2937–2946. 2012.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Zheng K, Dong Y, Yang R, Liang Y, Wu H and
He Z: Regulation of ferroptosis by bioactive phytochemicals:
Implications for medical nutritional therapy. Pharmacol Res.
168(105580)2021.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Khojah HM, Ahmed S, Abdel-Rahman MS and
Elhakeim EH: Resveratrol as an effective adjuvant therapy in the
management of rheumatoid arthritis: A clinical study. Clin
Rheumatol. 37:2035–2042. 2018.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Samsami-Kor M, Daryani NE, Asl PR and
Hekmatdoost A: Anti-inflammatory effects of resveratrol in patients
with ulcerative colitis: A randomized, double-blind,
placebo-controlled pilot study. Arch Med Res. 46:280–285.
2015.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Samsamikor M, Daryani NE, Asl PR and
Hekmatdoost A: Resveratrol supplementation and
oxidative/anti-oxidative status in patients with ulcerative
colitis: A randomized, double-blind, placebo-controlled pilot
study. Arch Med Res. 47:304–309. 2016.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Movahed A, Raj P, Nabipour I, Mahmoodi M,
Ostovar A, Kalantarhormozi M and Netticadan T: Efficacy and safety
of resveratrol in type 1 diabetes patients: A two-month preliminary
exploratory trial. Nutrients. 12(161)2020.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Ghavipour M, Sotoudeh G, Tavakoli E, Mowla
K, Hasanzadeh J and Mazloom Z: Pomegranate extract alleviates
disease activity and some blood biomarkers of inflammation and
oxidative stress in rheumatoid arthritis patients. Eur J Clin Nutr.
71:92–96. 2017.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Petramfar P, Hajari F, Yousefi G, Azadi S
and Hamedi A: Efficacy of oral administration of licorice as an
adjunct therapy on improving the symptoms of patients with
Parkinson's disease, A randomized double blinded clinical trial. J
Ethnopharmacol. 247(112226)2020.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Lin D, Zhang M, Luo C, Wei P, Cui K and
Chen Z: Targeting ferroptosis attenuates inflammation, fibrosis,
and mast cell activation in chronic prostatitis. J Immunol Res.
2022(6833867)2022.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Zhao T, Yang Q, Xi Y, Xie Z, Shen J, Li Z,
Li Z and Qin D: Ferroptosis in rheumatoid arthritis: A potential
therapeutic strategy. Front Immunol. 13(779585)2022.PubMed/NCBI View Article : Google Scholar
|
